OPEN END TURBO LONG - ARKEMA Stock

Certificat

DE000MB8DL51

Market Closed - Börse Stuttgart 12:50:47 2024-05-31 pm EDT
1.67 EUR -4.02% Intraday chart for OPEN END TURBO LONG - ARKEMA
Current month-6.18%
1 month-6.18%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart ARKEMA
Chart OPEN END TURBO LONG - ARKEMA
Date Price Change
24-05-31 1.67 -4.02%
24-05-30 1.74 +10.83%
24-05-29 1.57 -14.67%
24-05-28 1.84 +4.55%
24-05-27 1.76 +1.73%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 12:50 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ARKEMA
Issuer Morgan Stanley
WKN MB8DL5
ISINDE000MB8DL51
Date issued 2023-07-06
Strike 76.85
Maturity Unlimited
Parity 10 : 1
Emission price 1.29
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.66
Lowest since issue 0.73

Company Profile

Arkema is one of the world's leaders in the development, manufacturing and marketing of chemical products. Net sales break down by family of products as follows: - advanced materials (37.4%): high performance polymers, specialty surfactants, molecular sieves, organic peroxides, oxygenates, etc.; - adhesives (28.5%): sealants, adhesives for floors and tiles, waterproofing products, etc.; - coating solutions (25.3%): resins, emulsions for adhesives, surface coating products, absorbents, etc.; - intermediate products (8.4%): thermoplastic polymers (PMMA), acrylic products, fluorinated gases, etc.; - other (0.4%). At the end of 2023, the group had 148 production sites worldwide. Net sales are distributed geographically as follows: France (7.8%), Europe (26.6%), United States-Canada-Mexico (36.5%), China (11%), Asia (12.6%) and others (5.5% ).
Sector
-
More about the company

Ratings for Arkema

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Arkema

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
93.75 EUR
Average target price
112 EUR
Spread / Average Target
+19.47%
Consensus